# A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere

> **NCT01303510** · PHASE4 · COMPLETED · sponsor: **Crucell Holland BV** · enrollment: 111 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inflexal V

## Key facts

- **NCT ID:** NCT01303510
- **Lead sponsor:** Crucell Holland BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2013-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303510, "A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01303510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*